glp-1 drugs and breast cancer The Impact Safety of GLP‐1 Agents and Ending Breast Cancer Forever |

Thirdly, residual confounding is a possibility owing to the observational nature of the study

Unlike standard prescription drugs, compounded medications are not reviewed or approved by the FDA, meaning the agency does not assess their safety, effectiveness, or quality before they are distributed

Zepbound, KwikPen, and LillyDirect are registered trademarks, and Foundayo is a trademark of Eli Lilly and Company

Sherrill CH, Hwang AY

"For consumers, the bottom line is simple: If a product claims to work 'just like a GLP-1 drug,' promises dramatic weight loss, or minimizes risk with slogans like 'all the benefits without the discomfort,' that should be a red flag," Ventura says